Gene · 10666
Papers4,079
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 4,079
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Re-Tooling of γδ T Cells for Cancer Immunotherapy Using Advanced Manufacturing and Genetic Engineering. | Cells | 2026 | 41892285 | PubTator, text mining | PubMed |
| γδ T cells at the interface of innate and adaptive immunity in cancer. | J Immunother Cancer | 2026 | 41871873 | PubTator, text mining | PubMed |
| 5-Hydroxymethylcytosine profiles in circulating cell-free DNA serve as potential biomarkers for diagnosis and classification of adenomyosis. | EBioMedicine | 2026 | 41861514 | PubTator, text mining | PubMed |
| Maternal opioid use disorder and hepatitis C infection in pregnancy reshape the peripheral immune landscape at term. | EBioMedicine | 2026 | 41849830 | PubTator, text mining | PubMed |
| Regulation of the immune CD155-CD226-TIGIT axis by cyclin D-CDK4/6. | Proc Natl Acad Sci U S A | 2026 | 41849398 | PubTator, text mining | PubMed |
| Monocytes from inflammatory arthritis patients accumulate methotrexate and their transcriptome predicts methotrexate clinical response. | Cell Mol Life Sci | 2026 | 41840229 | PubTator, text mining | PubMed |
| Beyond CAR-T and oncology: broadening chimeric antigen receptor technologies across cell types and diseases. | Precis Clin Med | 2026 | 41836149 | PubTator, text mining | PubMed |
| CLL-1: An emerging target for immunotherapy in acute myeloid leukemia. | Ann Hematol | 2026 | 41830967 | PubTator, text mining | PubMed |
| TIGIT Blockade Potentiates the Anti-Leukemic Activity of Exercise-Mobilized Donor Lymphocytes and Expanded γδ T-Cells. | Cancers (Basel) | 2026 | 41827731 | PubTator, text mining | PubMed |
| Phase Ib multicenter study of anti-TIM-3 (S095018/Sym023) in combination with anti-PD-1 (Sym021) in patients with advanced/metastatic recurrent biliary tract cancer. | J Immunother Cancer | 2026 | 41825935 | PubTator, text mining | PubMed |
| Protein-level profiling of TIGIT axis components in human PDAC reveals immune-suppressive expression patterns. | Cancer Immunol Immunother | 2026 | 41805925 | PubTator, text mining | PubMed |
| Regulatory T Cell Heterogeneity in the Steady State and Tumor. | Immune Netw | 2026 | 41800022 | PubTator, text mining | PubMed |
| Mechanisms of tumor cell evasion from NK cell-mediated killing and advances in NK cell-based cancer immunotherapy. | Pharm Sci Adv | 2026 | 41799416 | PubTator, text mining | PubMed |
| Antibody screening for tumor and immune hotspot targets: The frontier of new methods and technologies. | J Pharm Anal | 2026 | 41798069 | PubTator, text mining | PubMed |
| Unraveling Immune Checkpoint Inhibitor-Associated Cardiovascular Toxicities: Pathway Insights, Mechanisms, and Emerging Therapeutic Targets. | Rev Cardiovasc Med | 2026 | 41789342 | PubTator, text mining | PubMed |
| Enhancing cancer killing and natural killer cell persistence by targeting NOXA, a predictor of poor patient survival. | Mol Ther Oncol | 2026 | 41783357 | PubTator, text mining | PubMed |
| APOs as promising prognostic biomarkers: correlation with tumor-infiltrating leukocytes in endometrial cancer. | Front Immunol | 2026 | 41777895 | PubTator, text mining | PubMed |
| Immune Exhaustion in Chronic Infection and Cancer: Signaling Pathways and Therapeutic Interventions. | MedComm (2020) | 2026 | 41768369 | PubTator, text mining | PubMed |
| Poliovirus receptor (PVR) expression as a predictor of relapse in colorectal cancer: bioinformatics and virtual screening. | Exp Biol Med (Maywood) | 2026 | 41767749 | PubTator, text mining | PubMed |
| Advances in immunotherapy for thyroid malignancies: from molecular targets to clinical outcomes. | Front Med (Lausanne) | 2026 | 41767494 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10666/papers?page=3